腫瘤劑量 的英文怎麼說

中文拼音 [zhǒngliújìliáng]
腫瘤劑量 英文
tumor dose
  • 腫 : Ⅰ名詞（隆起處） swelling Ⅱ動詞（突起） swell; be swollen
  • 瘤 : 名詞（瘤子） tumour
  • 劑 : Ⅰ名詞1 （藥劑; 制劑） a pharmaceutical or other chemical preparation 2 （某些有化學作用的物品） a...
  • 量 : 量動1. （度量） measure 2. （估量） estimate; size up
  • 腫瘤 : tumour; core （綿羊體內的）; neoplasm; phyma
  • 劑量 : [物理學] [醫學] dosage; dose; dosis劑量槽 dosage bunker; 劑量測定（法） dosimetry; health work; ...
  1. " body gamma knife is mainly used for curing all kinds of body tumors, and the latest generation three - dimensional directional actinotherapy devices. it incorporates many modern high - techs and effectively break through the limit of actinotherapy devices available while precisely focused and three - dimensional directional. it also has adjusted actinotherapy, wide range irradiation and common actinotherapy, and protects the normal organism from damage at best while its dosage precisely destroys tumor organism

    「體部伽瑪刀」主要用於治療各種體部腫瘤，是目前世界上最新一代立體定向放療設備，它吸收了眾多現代高新技術成果，有效地突破了現有放射治療設備的局限，兼備精確聚焦立體定位等優點，具有適形調強放療大野照射及普通放療等多種功能，能夠在劑量準確摧毀腫瘤組織的同時，最大程度地保護正常組織免受損傷。
  2. Comprehensive cellular responses was found in human amnion fl cells following exposure to low concentration of mnng, such as the lowering of dna replication fidelity resulted from alteration of dna polymerase profile ; activation of a lot of transcription factors, such as api, creb, nf - kb etc ; clustering of egfr ( epidermal growth factor receptor ) and tnfr ( tumor necrosis factor receptor ) and activation of camp - pka - creb and jnk / sapk signal pathways

    我們發現，低劑量mnng處理后的人羊膜fl細胞有廣泛的細胞反應，並有多個信號轉導通路的激活和基因表達的改變。例如dna復制保真度下降， dna聚合酶譜發生改變，應用報告基因技術和底物磷酸化檢出技術證明細胞一系列轉錄因子如ap1 、 creb 、 nf b等被激活，細胞表面受體如表皮生長因子受體、腫瘤壞死因子受體發生聚簇，細胞信號轉導通路camp - pka - creb和jnk sapk被激活。
  3. The widespread use of x - ray in medical diagnosis and treatment for some diseases in the early 30 s without realizing its harmful effects led to cases of radiation dermatitis and chronic ulceration, eventually resulting in radiation induced cancers. following these, various radiation induced malignances surfaced one after another, drawing attention on the detrimental effects due to radiation

    在30年代初期， x射線和放射性核素曾應用於治療某些疾病。由於病人累積過高劑量，曾誘發白血病和肝癌、骨癌等惡性腫瘤。其後種種因輻射而誘發的疾病相繼發現，引起了人們對輻射危害的關注。
  4. Mdr1 express product p - glycoprotein was detected by immunocytochemical method and flowcytometry. the cytotoxicity and multidrug resistance reversion effect of tea polyphenol was examined by mtt assay in mcf - 7 and mcf - 7 adr carcinoma cell lines, and compared with pgp inhibitor quinidine. the pgp expression of mcf - 7 adr was strongly positive, the positive rate was 15 % ; the pgp expression of mcf - 7 was negative, the positive rate was 1. 8 %. ic50 of tea polyphenol to mcf - 7 and mcf - 7 adr is 115. 2g ml and 207. 6g ml respectively. ic50 of quinidine to mcf - 7 and mcf - 7 adr is 129. 8mol l 42. 1g ml and 94. 1mol l 30. 5g ml respectively. tea polyphenol and quinidine changed little toxicity of adriamycin to mcf - 7, but tea polyphenol and quinidine improved the sensitivity of mcf - 7adr to adriamycin significantly. immunocytochemistry and flow cytometry can detect p - glycoprotein expression level qualitatively and quantitatively. tea polyphenol is not only an anti - tumor agent, but also a multidrug resistant modulator similar as quinidine. tea polyphenol is advantageous for its little toxicity in tumor treatment

    用免疫組化法和流式細胞儀對腫瘤細胞系mcf - 7和mcf - 7 adr的p -糖蛋白表達水平進行定性定量研究。用噻唑藍比色法mtt研究茶多酚的細胞毒性及其對耐藥性的逆轉作用，並與pgp抑制劑奎尼定進行了比較。免疫組化法檢測p -糖蛋白表達水平， mcf - 7 adr呈強陽性，而mcf - 7呈陰性流式細胞儀定量檢測結果mcf - 7 adr細胞系細胞陽性率為15 % ， mcf - 7細胞系細胞陽性率為1 . 8 % 。
  5. Studies of the crystal structure of endostatin have shown a compact globular fold, with one face particularly rich in arginine residues acting as a heparin - binding epitope, this site was recently shown to be involved in the inhibition of induced angiogenesis. experimental studies show that recombinant endostatin specifically inhibits the proliferation of endothelial cells in a dosedependent fashion. recombinant endostatin from bacteria is largely insoluble, but still efficient in arresting tu mor growth after injection into mice. intermittent therapy with recombinant bacterially produced endostatin reduces several experimental tumors, including lewis lung carcinoma, to a dormant state. no sign of drug induced resistance has been reported and, in the original study, the treatment dormancy appeared to persist even when therapy was discontinued. sowe regard endostatin as a promising anti - tumor drug

    許多研究表明重組內皮抑素特異性抑制內皮細胞增殖，而且這種抑制作用呈劑量依賴性。細菌表達產物內皮抑素大部分以不溶形式存在，將這種混懸液注射治療老鼠仍可以抑制腫瘤生長。于小鼠皮下重復注射內皮抑素重組蛋白，幾乎完全抑制鼠lewis肺癌等多種腫瘤生長，並無耐藥性產生，即使中斷治療腫瘤也不再復發。
  6. The characteristics of this method are : a, directly counting cell number without the influence of the metabolic state of the cells ; b, discrimination of target cells from effector cells in cell - mediated cytotoxicity assay ; c, less treatment step, and free - radioactivity ; d, high sensitivity and reliability. 2, using the above assay, immunofluorescent labeled technique, and flow cytometry, the pbmc proliferation, apoptosis, necrosis, cell cycle, activation, cytokines and membrane marker were detected. the results showed that the number of pbmc reduced, but the activity of pbmc increased dose - dependently ; the reduction of cell number resulted from necrosis and apoptosis ; the supernatant of k562 cell lines were not able to block the cell cycle, but to promote it ; the ratio of t cell subset and the expression of thl and th2 cytokines increased

    結合以上創建的方法和免疫熒光流式細胞術，用k562細胞株可溶性分泌物（上清）對外周血單個核細胞（ pbmc ）進行培養以模擬體內微環境，然後分別從細胞增殖、凋亡、壞死、細胞周期、活性、細胞因子和表面抗原表達等方面進行研究，結果發現用腫瘤上清培養的pbmc細胞數量下降明顯，但同時對其有激活作用，且呈劑量依賴性；細胞數的下降主要是由細胞壞死和凋亡引起的，腫瘤上清對細胞周期沒有阻斷作用，反而略有促進作用； t細胞亞群比例增加，並促進表達th1 、 th2細胞因子。
  7. This equipment utilizing the principal of rtaary focusing, the technique of double barriers and auomatic program, fulfils the breakthrough on high - dose, high precision conformal radiotherapy thechnique. it is integrated with advanced omagine equipment such as ct, mri and pet, and also with the world most advanced 128 guide double - video synchronied electro - encephalographic long - distance monitoring system for evaluation of eepilepsy patients pre - operation, in the operation and after operation. it combines multi - academic branches such as the department of neural medicine, neurosurgery, oncology, radiotherapy and imaginary, to form a combined therapeutic system

    擁有世界先進的大型醫療設備旋轉式頭部體部伽瑪刀，該設備利用旋轉聚焦原理雙重屏蔽技術及自動化的治療程序，實現了大劑量高精度適形放療的技術突破，與先進的ct mri pet等影像設備及世界最先進的128導全數字化癲癇術前術中術后定位評估系統實現配套，形成了聯系神經內外科腫瘤科放療科影像科等多學科的綜合治療體系。
  8. Method used in analyzing and controlling dosage of hifu for tumor therapy

    高強度聚焦超聲腫瘤治療劑量分析和控制系統
  9. Vitamin c can remission the symptom of cancer patien and lengthen life span, but the relationship of it and telomerase was not reported. cisplatin is widely administrated in cancer therapy, it is cell cycle non - specific agent and is combined with other drugs. the caov3 cells were cultured in medium containing different concentrations vitamin c and for different time

    研究發現，人體內必須的營養物質維生素c （ vc ）可降低抗腫瘤藥的毒副作用，並具有抗腫瘤的能力，給各類晚期癌癥患者大劑量注射vc ，具有顯著緩解腫瘤患者癥狀並延長壽命的作用，但目前對vc抗腫瘤作用機制還不清楚。
  10. Results the experiment manifested that the compensator fabricated by the way could make the high dosage shape of target in accordance with the form of tumor and could adjust the distribution of the dosage according to remedy requirement

    結果：實驗和研究表明，運用該方法製作的三維熔鉛調強擋塊，不僅能實現靶區高劑量的形狀在三維方向上與腫瘤的形狀一致，而且可時照射野內劑量分佈按要求的方式調整。
  11. Professor fung said, " the data from the pre - clinical studies indicates that the anti - cancer product developed by ck life sciences has the ability to strengthen the immune system in tumor - bearing mice and suppress the growth of tumors in mice in a time - and dose - dependent manner - an encouraging result indeed.

    馮國培教授指出：一系列的臨床前測試初步顯示長江生命科技之抗癌產品確能增強免疫功能，亦能在一定劑量及時間下，控制癌腫瘤的生長，這是令人鼓舞的訊息。
  12. Results and conclusion : the extracted esophageal boundary variations between adjacent time frame sequences can be applied to estimate the tumor motions as well as the required safe margins

    結論：移動評估的結果，有利於治療計畫中安全邊距的縮小，在腫瘤治療劑量增加時仍能有效控制正常組織所接受之劑量，降低正常組織副作用發生機率及其發生的嚴重程度。
  13. Whereas full dose radiation therapy of the cancer should be performed after resection as suggested by the literature, we believe pre - operative low - dose radiation therapy may help the execution of tumor resection and thus the general outcome of the patient

    就算放療主要之治療劑量應在腫瘤切除后再施予，我們相信術前低劑量之放療對幫助病患腫瘤之切除和臨床整體結果有正面效益。
  14. In order to further investigate the role of axudl in human tumor carcinogenesis and the potential association between the axudl gene expression status and the stimulation of transforming growth factor beta in human cancers, the present study was performed in three aspects as follows : ( 1 ) cloning full length enconding region cdna of axudl and construction of eukaryotic vector that expression the fusion protein of axud1 and influenza virus hemagglutin ha epitope tag ; ( 2 ) exploring the time and dose effects of tgf - 1 on the expression - of axudl gene in hepg2 hepatoma cells and spc - a1 lung carcinomas cells, and studying the effects of overexpression of axud1 on the expression of cell cycle and apoptosis related protein in hepg2 hepatoma cells ; ( 3 ) construction and expression of human axudl in e. coli m15. the following main results and conclusions can be obtained from the present study : 1. the full length ecnoding region of human axudl cdna from human peripheral blood lymphocytes was successfully cloned using one step rt - pcr method, and constructed into a eukaryotic expression vector which can be expressed a ha - axud1 fusion protein with axud1 and influenza virus hemagglutin ha epitope tag. the recombinant plasmid was identified by polymerase chain reaction, restriction endonuclease maping and sequencing, this expression vector might be instrumental to further study the function of axud1 protein in tumor cells

    為了進一步研究axud1在人類腫瘤發生中的作用及axud1基因的表達狀況與tgf -介導的信號通路的關系，本實驗研究分為三個部分： （ 1 ） axud1基因cdna全長編碼區的克隆和ha表位標記的axud1基因表達載體的構建； （ 2 ）探討肝癌細胞hepg2和肺腺癌spc - a1細胞中tgf - 1誘導的axud1基因表達的時間、劑量效應以及誘導表達的可能機理，並研究axud1的過表達對細胞周期和細胞凋亡相關蛋白表達的影響； （ 3 ） axud1原核表達載體的構建及其在大腸桿菌中的表達。本實驗的主要結果和結論如下： 1利用一步法rt - pcr成功地從人類外周血淋巴細胞中克隆出axud1基因編碼區cdna ，並將其構建入真核表達載體中，編碼的ha - axud1融合蛋白帶有流感病毒凝血素ha的表位標記肽段。
  15. How it works : instead of hilling a tumor with large beams of radiation from only a few directions, as is done with conventional radiotherapy, peacock calculates precise angles and dosed using a computer and ct scan

    工作原理傳統的放射治療是從幾個方向用大量的放射性光束來攻擊腫瘤，而「孔雀』則是用計算機和ct掃描儀計算出腫瘤的精確角度和輻射吸收劑量。
  16. Clinical observation on treating malignant pleural effussion with both gaojusheng and cisplatin

    低劑量氟脲嘧啶輸注順鉑腹腔灌注聯合熱療治療惡性腫瘤肝轉移療效觀察
  17. Liao zx, travis el, tucker sl. damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung. int j radiat oncol biol phys, 1995, 32 : 1359

    尹勇，于金明，邢力剛.劑量體積直方圖參數評估放射性肺損傷的作用.中華腫瘤雜志， 2003 ， 25 : 313 - 315
  18. Men who took 30 mg of the supplement ( the quantity found in 2 lbs to 3 lbs of tomatoes ) had lower levels of prostate - specific antigen - an indicator of cell growth - and smaller tumors

    患者每日補充30毫克（可從2 3磅西紅柿中吸收這樣的劑量） ，其體內前列腺部位抗原（能顯示細胞腫瘤）的水平下降，且腫瘤也變小了。
  19. The originalities of this paper are : 1, development of a a flow cytometry - based assay for quantitative analysis of cellular proliferation and cytotoxicity in vitro ; 2, the soluble secretion of k. 562 cell lines reduce the number of pbmc, but promote the activity of pbmc in dose - dependent manner ; 3, soluble secretion of k562 cell lines can induce the no production by pbmc, but no only plays a part of the role of soluble secretion of k562 cell lines ; 4, establishing a in vitro model and giving some parameters for sreening and appraising anti - tumor medicine

    本研究的創新點在於： l 、建立了用流式細胞術定量測定細胞增殖和細胞毒性的直接檢測技術； 2發現k562可溶性分泌物劑量依賴性地使pbmc細胞數量減少但活性增加； 3 、 k562可溶性分泌物能誘導pbmc產生no ，但是no的作用並不等同於腫瘤上清的全部作用。 4 、為抗腫瘤藥物篩選提供了一個體外模型，並明確了一些篩選指標。
  20. Abstract : as viewed from developing rit, rit are discussed on the following points such as the effective absorbance dosage, selection of administration way, application in clinical experience both abroad and at home ， as well as the problems met in clinical application and the solving strageties

    文摘:從發展放射免疫治療的必要性出發，著重敘述其治療腫瘤的有效吸收劑量、多種給藥途徑的選擇以及在國內、外臨床實踐中的應用，並簡述其在臨床應用中所面臨的問題及解決策略。
分享友人
分享到 Line

分享到臉書